Researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) have begun bridging research for a vaccine to prevent and treat pollen disease caused by cedar pollen. This is the first pollen disease vaccine developed so far, and consists of fused cryptomeria (cedar) pollen antigens created by genetic engineering.
Pollen disease is a serious and growing problem in Japan, where an estimated 16% of the population is suffering from symptoms of the allergy, many of whom are living in cities. Besides the discomfort experienced by sufferers, the condition causes work absences and other social problems. Some people have even suffered anaphylactic shock from cedar pollen. Until now there has been no treatment, except for allopathy, such as antihistamines to suppress the symptoms of itchy eyes, runny nose and sneezing. The new vaccine offers the hope of a cure, or at least a way to stimulate the immune system to regulate the allergic response caused by pollen disease.
Yasuyuki Ishii and his colleagues at RCAI’s Vaccine Design Research Team synthesized two kinds of principle cryptomeria pollen antigens using genetic engineering techniques. They found from animal trials that the vaccine was effective in both treating the condition and reducing the likelihood of anaphylactic shock, a risk when natural cryptomeria pollen is present.
The bridging study aims to expand research into clinical applications in humans, to determine dose levels and toxicity levels. Human clinical trials are still needed, but a vaccine to stimulate the immune system to fight cedar pollen disease appears to be in sight.
A whole-body approach to understanding chemosensory cells
13.12.2017 | Tokyo Institute of Technology
Research reveals how diabetes in pregnancy affects baby's heart
13.12.2017 | University of California - Los Angeles Health Sciences
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.
To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...
The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.
Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...
With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong
Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
13.12.2017 | Health and Medicine
13.12.2017 | Physics and Astronomy
13.12.2017 | Life Sciences